BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2644989)

  • 1. c-myb but not c-myc suppresses the hemin-induced nonterminal expression of hemoglobin by murine erythroleukemia cells.
    Prochownik EV
    Blood; 1989 Feb; 73(3):782-6. PubMed ID: 2644989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemin does not cause commitment of murine erythroleukemia (MEL) cells to terminal differentiation.
    Gusella JF; Weil SC; Tsiftsoglou AS; Volloch V; Neumann JR; Keys C; Housman DE
    Blood; 1980 Sep; 56(3):481-7. PubMed ID: 6931622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
    Toffoli G; Viel A; Bevilacqua C; Maestro R; Tumiotto L; Boiocchi M
    Leuk Res; 1989; 13(4):279-87. PubMed ID: 2654492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium ionophore-induced transient down-regulation of c-myb mRNA levels in Friend erythroleukemia cells.
    Schaefer A; Stöcker U; Marquardt H
    J Biol Chem; 1993 May; 268(15):10876-80. PubMed ID: 8496152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myb effects on kinetic events during MEL cell differentiation.
    Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
    Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.
    Coppola JA; Parker JM; Schuler GD; Cole MD
    Mol Cell Biol; 1989 Apr; 9(4):1714-20. PubMed ID: 2657403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-myc proto-oncogene during podophyllotoxin induced IW32 erythroleukemia cell differentiation.
    Yen YT; Wu RT; Tang SJ; Wang FF
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1241-6. PubMed ID: 1930169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of murine erythroleukemia cell differentiation is associated with methylation and differential stability of poly(A)+ RNA transcripts.
    Vizirianakis IS; Tsiftsoglou AS
    Biochim Biophys Acta; 1996 Jun; 1312(1):8-20. PubMed ID: 8679720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
    Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
    Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA.
    Weber BL; Westin EH; Clarke MF
    Science; 1990 Sep; 249(4974):1291-3. PubMed ID: 2205003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation.
    Todokoro K; Ikawa Y
    Biochem Biophys Res Commun; 1986 Mar; 135(3):1112-8. PubMed ID: 3457564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells.
    Lo SC; Aft R; Mueller GC
    Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
    Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
    Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of beta-globin mRNA accumulation by heme in dimethyl sulfoxide (DMSO)-sensitive and DMSO-resistant murine erythroleukemia cells.
    Fukuda Y; Fujita H; Garbaczewski L; Sassa S
    Blood; 1994 Mar; 83(6):1662-7. PubMed ID: 8123858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early protooncogene expression during hemin-induced differentiation of human erythroleukemic cells.
    Griffin MO; Nelson JC; Abraham NG
    Leuk Res; 1990; 14(11-12):997-1006. PubMed ID: 2280614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins.
    Lyon JJ; Watson RJ
    Differentiation; 1995 Oct; 59(3):171-8. PubMed ID: 7589901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.